Font Size: a A A

Hyperthermic Intraperitoneal Chemotherapy With Recombinant Mutant Human TNF-α And Raltitrexed In The Preclinical Model With Colorectal Peritoneal Carcinomatosis

Posted on:2021-03-31Degree:MasterType:Thesis
Country:ChinaCandidate:Q Y GongFull Text:PDF
GTID:2404330605952490Subject:Pharmacy
Abstract/Summary:PDF Full Text Request
Colorectal cancer(CRC)is one of the gastrointestinal malignancies with high mortality.Peritoneal metastasis often occurs in advanced colorectal cancer,which is an important marker of poor prognosis.The current standard treatment for colorectal peritoneal carcinomatosis is cytoreductive surgery and then hypertheimic intraperitoneal chemotherapy(HIPEC),which can benefit patients.While the drugs used for HIPEC are limited and the absolute advantage of any specific drug cannot be derived,we need to develop new chemotherapeutic drugs to provide patients with more and better options.Recombinant mutant human tumor necrosis factor-α(rmhTNF)was obtained by modifying TNF-α.rmhTNF has been used to treat malignant pleural effusions,non-Hodgkin’s lymphoma and non-small cell lung cancer in clinic.Raltitrexed(RTX)is an inhibitor of thymidylate synthetase,which is effective against a variety of cancers,especially advanced CRC.In this research,the effect of rmhTNF on human CRC cells,the synergistic effect of rmhTNF and hyperthermia(42℃,HT),and the therapeutic effect of rmh TNF and RTX with HIPEC on the mouse model with colorectal peritoneal carcinomatosis were studied by using in vitro and in vivo experimental methods.The results showed that rmhTNF could induce death in human CRC cells in a dose-dependent and time-dependent manner.In addition,HT enhanced rmhTNF-mediated cell death in human CRC cells,indicating that rmhTNF had synergistic effect with HT.Besides,rmhTNF combined with RTX could enhance the toxicity to human CRC cells,upregulate the expression of pro-apoptotic protein and promote cell apoptosis.A series of in vivo experimental methods were conducted in the mouse model with colorectal peritoneal carcinomatosis,and we found that HIPEC with rmhTNF and RTX could inhibit the growth and spread of tumor,upregulate the expression of pro-apoptotic protein in tumor tissue and enhance the apoptotic level of tumor tissue and cause irreversible cell damage without any serious toxic and side effects.Collectively,rmhTNF and RTX significantly inhibited the activity of colorectal cancer cells under the effect of HT in vitro,and HIPEC with rmhTNF and RTX had a great therapeutic effect on colorectal peritoneal carcinomatosis in mice,which could provide experimental data and basis for the clinical treatment of colorectal peritoneal carcinomatosis.
Keywords/Search Tags:colorectal peritoneal carcinomatosis, hyperthermic intraperitoneal chemotherapy, recombinant mutant human TNF-α, raltitrexed, pharmacodynamics
PDF Full Text Request
Related items
Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy For Peritoneal Carcinomatosis Of Colorectal Origin
Cytoreductive Surgery And Hyperthermic Intraperitoneal Chemotherapy For Advanced Colorectal Cancer And High Risk Of Developing Colorectal Peritoneal Carcinomatosis:Short-term Efficacy And Security Report
Efficacy And Safety Study Of Hyperthermic Intraperitoneal Chemotherapy After Colectomy In Patients With Colorectal Cancer At High Risk Of Peritoneal Carcinomatosis
Effect Of Hyperthermic Intraperitoneal Chemotherapy On Immune Microenvironment In Patients With Peritoneal Carcinomatosis
The Prognosis Analysis Of Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy In Patients With Peritoneal Carcinomatosis Of Colorectal Cancer
Prognostic Analysis And Risk Of Postoperative Complications Of Hyperthermic Intraperitoneal Chemotherapy(HIPEC) In Gastric Cancer Patients With Peritoneal Metastases
Clinical Study Of Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy To Treat Epithelial Ovarian Cancer And Primary Peritoneal Serous Carcinoma
Clinical Analysis Of Hyperthermic Intraperitoneal Chemotherapy Combined With Systemic Chemotherapy In The Treatment Of T4 Colorectal Cancer
Clinical Efficacy Of Intraperitoneal Hyperthermic Perfusion Chemotherapy In Patients With Colorectal Cancer
10 The Efficacy And Safety Of Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy For Gastric Cancer With Peritoneal Carcinomatosis:A Meta-analysis